Speech Treatment for Minimally Verbal Children with Autism
(TxMVASD+CAS Trial)

Recruiting in Palo Alto (17 mi)

Age: < 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: MGH Institute of Health Professions

No Placebo Group

Trial Summary

What is the purpose of this trial?Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.

Eligibility Criteria

This trial is for minimally verbal children with Autism Spectrum Disorder who can repeat at least 2 syllables and meet the criteria for Childhood Apraxia of Speech. They should not speak more than 20 words or phrases and must be exposed to English at least half the time. Children with poorly controlled seizures, sensory disabilities, or severe behavioral issues cannot participate.

Inclusion Criteria

I have been diagnosed with Childhood Apraxia of Speech.

I can repeat at least two syllables correctly.

You have been diagnosed with Autism Spectrum Disorder.

+2 more

Exclusion Criteria

The child has behavior issues that make it difficult for them to take part in the study.

You have difficulty speaking due to being blind or deaf.

English is spoken less than half the time in my home.

+1 more

Participant Groups

The study tests a speech treatment designed specifically for children with both autism and CAS (a speech movement planning disorder). It aims to see if this tailored therapy helps improve their ability to speak.

1Treatment groups

Experimental Treatment

Group I: CAS Treatment for MV ASDExperimental Treatment1 Intervention

Participants will receive CAS treatment, modified for minimally verbal children with autism